Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Clinical trial NCT05183035 · RECRUITING

Trial details

NCT number: NCT05183035
Sponsor: PedAL BCU, LLC
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2022-10-01
Primary completion: 2027-02-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.